
Marko van Treeck
Featured in:
Articles
-
Sep 3, 2024 |
medrxiv.org | Isabella C. Wiest |Fabian Wolf |Marie-Elisabeth Lessmann |Marko van Treeck
JNK declares consulting services for Owkin, France; DoMore Diagnostics, Norway; Panakeia, UK; AstraZeneca, UK; Scailyte, Switzerland; Mindpeak, Germany; and MultiplexDx, Slovakia. Furthermore he holds shares in StratifAI GmbH, Germany, has received a research grant by GSK, and has received honoraria by AstraZeneca, Bayer, Eisai, Janssen, MSD, BMS, Roche, Pfizer and Fresenius. ICW has received honoraria by AstraZeneca. No further potential COIs are disclosed by any of the authors.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →